November 18, 2010
Fast Forward, LLC and Provid Pharmaceuticals Announce Expansion of their Partnership for the Development of PV-267, Provid’s Unique MS Drug Candidate
- /
- /
NEW YORK and NORTH BRUNSWICK, N.J., Nov. 17, 2010 /PRNewswire/ — Provid Pharmaceuticals, Inc, a drug discovery company, and Fast Forward, LLC, the National Multiple Sclerosis…
